Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.430
-0.030 (-0.67%)
At close: Feb 27, 2026, 4:00 PM EST
4.280
-0.150 (-3.39%)
After-hours: Feb 27, 2026, 7:47 PM EST
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $410.54 million as of February 27, 2026. Its market cap has decreased by -44.53% in one year.
Market Cap
410.54M
Enterprise Value
278.79M
1-Year Change
-44.53%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $410.54M, an increase of 44.25%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 410.50M | 29.05% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 426.88M |
| Enanta Pharmaceuticals | 424.84M |
| Upstream Bio | 418.26M |
| LENZ Therapeutics | 413.65M |
| Absci | 412.02M |
| Immutep | 408.84M |
| PureTech Health | 407.02M |
| Bicycle Therapeutics | 397.48M |